MDR remains a major impediment to the treatment of cancers as its resulting ineffectiveness of the drug treatment is responsible for a larger percentage (about 90%) of cancer-related deaths (Li et al., 2008; Longley & Johnston, 2005; Si et al., 2019), hence the role of ABC transporters which contribute to MDR cannot be overlooked. The gene discussed is ABCG2; the disease is cancer.